Candel Therapeutics, Inc. is a late clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
42
Frequently Asked Questions
What is Market Cap of Candel Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Candel Therapeutics Inc market cap is $248.96M.
What is the 52-week high for Candel Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Candel Therapeutics Inc 52 week high is $14.30 as of June 05, 2024.
What is the 52-week low for Candel Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Candel Therapeutics Inc 52 week low is $0.66 as of June 05, 2024.
What is Candel Therapeutics Inc stock price today?
Candel Therapeutics Inc stock price today is $8.04.
What was Candel Therapeutics Inc stock price yesterday?
Candel Therapeutics Inc stock price yesterday was $8.37.
What is the PE ratio of Candel Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Candel Therapeutics Inc’s P/E ratio is -6.50.
What is the Price-to-Book ratio of Candel Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Candel Therapeutics Inc P/B ratio is 41.0838.
What is Candel Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Candel Therapeutics Inc's EBITDA is -1.18.
What is the 50-day moving average of Candel Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Candel Therapeutics Inc 50-day moving average is $7.15.
How many employess does Candel Therapeutics Inc has?